We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 15

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Australian Federal Court upholds Myriad’s gene patent

  • Morrison & Foerster LLP
  • -
  • Australia, USA
  • -
  • February 15 2013

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld

BLG Monthly Update

  • Borden Ladner Gervais LLP
  • -
  • Argentina, Australia, Canada, United Kingdom, USA
  • -
  • December 19 2012

The BLG Monthly Update is a digest of recent developments in the law which Neil Guthrie, our National Director of Research, thinks you will find

Rudd Center study examines obesity-related health messaging

  • Shook Hardy & Bacon LLP
  • -
  • Australia, United Kingdom, USA
  • -
  • September 14 2012

Researchers with Yale University’s Rudd Center for Food Policy and Obesity have published a study purportedly assessing the effectiveness of “major obesity public health campaigns from the United States, the United Kingdom and Australia.”

Managing your risks under global anti-corruption regimes

  • Piper Alderman
  • -
  • Australia, United Kingdom, USA
  • -
  • September 13 2012

Pharmaceutical and medical device companies operate in a stringent regulatory environment

European Commission ups the cost of paying for delay

  • King & Wood Mallesons
  • -
  • Australia, European Union, USA
  • -
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

Government procurement in the health sector under the Australia United States free trade agreement (FTA)

  • Baker & McKenzie
  • -
  • Australia, USA
  • -
  • August 7 2012

This alert provides an outline of procurement practices that Australian public sector health bodies should be applying in their procurements to give effect to obligations under the FTA

Biotech Life Sciences trade mission to Australia announced

  • Shook Hardy & Bacon LLP
  • -
  • Australia, USA
  • -
  • June 21 2012

The U.S. Department of Commerce, International Trade Administration and U.S. and Foreign Commercial Service have announced an October 29-November 2, 2012, Biotech Life Sciences trade mission to Australia

Social media, not social medicine

  • Barry.Nilsson. Lawyers
  • -
  • Australia, USA
  • -
  • November 14 2011

Only people beyond a certain vintage would understand the connection between a cassette tape and a pencil

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy